Similar Adverse Events & Complications with Aspirin vs Enoxparin for Hip/Knee Arthroplasty Patients .
This report has been verified
by one or more authors of the
original publication.
Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis
Orthop Traumatol Surg Res. 2021 Feb;107(1): 102606.Four randomized controlled trials including 1507 adult patients with osteoarthritis (OA) undergoing an elective hip or knee arthroplasty were included in this meta-analysis comparing the use of aspirin to enoxaparin after surgery for thromboprophylaxis. The primary outcomes of interest included incidence of venous thromboembolism (VTE) and mortality, which were evaluated up to 3-months post-surgery. Secondary outcomes of interest included the incidence of major bleeding events (i.e. re-operation due to organ, limb or muscle function compromise) and minor bleeding events (i.e. infection, wound ooze/minor bleed). Pooled results revealed that no statistical significant difference were observed for all primary and secondary outcomes (p>0.05 for all).
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
